Apply to trial NCT06394011

A few quick questions so the study team can decide if you might be a fit.

RecruitingPhase 2Drug trial

Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients

The purpose of this study is to evaluate the efficacy and safety of VA combined with HAAG in the induction treatment of newly diagnosed acute myeloid leukemia.

How this works

  1. Answer a few questions

    About 5 to 10 minutes. Skip-friendly where possible.

  2. We forward your profile to the study team

    They see only the answers needed to decide if you can be screened.

  3. The team reaches out to schedule screening

    Usually within a few business days, via the contact you give.

We save your progress under this email so you can come back later, and the study team uses it to reach you.

By clicking Start, you agree to our terms of service.